Anti-CTLA-4 and anti-PD-1 immunotherapies repress tumor progression in preclinical breast and colon model with independent regulatory T cells response-Reference-Cited by-同舟云学术

Anti-CTLA-4 and anti-PD-1 immunotherapies repress tumor progression in preclinical breast and colon model with independent regulatory T cells response

Published:2022-06 Issue: Volume:20 Page:101405
ISSN:1936-5233
Container-title:Translational Oncology
language:en
Short-container-title:Translational Oncology

Author:

Rupp Tristan^ORCID,Genest Laurie^ORCID,Babin David,Legrand Christophe,Hunault Marion,Froget Guillaume,Castagné Vincent^ORCID

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference75 articles.

1. The tumor microenvironment and its contribution to tumor evolution toward metastasis;Lorusso;Histochem. Cell Biol.,2008

2. Development of PD-1 and PD-L1 inhibitors as a form of cancer immunotherapy: a comprehensive review of registration trials and future considerations;Gong;J. Immunother. Cancer,2018

3. Cancer immunotherapy: the beginning of the end of cancer?;Farkona;BMC Med.,2016

4. Immune checkpoint targeting in cancer therapy: towards combination strategies with curative potential;Sharma;Cell,2015

5. Dual CTLA-4 and PD-L1 blockade inhibits tumor growth and liver metastasis in a highly aggressive orthotopic mouse model of colon cancer;Fiegle;Neoplasia,2019

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Harnessing the capacity of phytochemicals to enhance immune checkpoint inhibitor therapy of cancers: A focus on brain malignancies;Cancer Letters;2024-07

2. Histoplasty Modification of the Tumor Microenvironment in a Murine Preclinical Model of Breast Cancer;Journal of Vascular and Interventional Radiology;2024-06

3. Membrane Fusion Liposomes Deliver Antifibrotic and Chemotherapeutic Drugs Sequentially to Enhance Tumor Treatment Efficacy by Reshaping Tumor Microenvironment;Advanced Healthcare Materials;2024-05-11

4. Bridging the Gap from Bench to Bedside: A Call for In Vivo Preclinical Models to Advance Endometrial Cancer and Cervical Cancer Immuno-oncology Research;Clinical Cancer Research;2024-04-25

5. Understanding the Tumor Microenvironment in Melanoma Patients with In-Transit Metastases and Its Impacts on Immune Checkpoint Immunotherapy Responses;International Journal of Molecular Sciences;2024-04-11